BlackRock Advisors’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

BlackRock Advisors’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-16,390	Closed	-$676K	–	3832
2015 Q2	$676K	Buy	16,390 +638	+4%	+$22.9K	﹤0.01%	1952
2015 Q1	$555K	Buy	15,752 +2,244	+17%	+$75.9K	﹤0.01%	1999
2014 Q4	$434K	Sell	13,508 -687	-5%	-$19.9K	﹤0.01%	2098
2014 Q3	$398K	Sell	14,195 -208	-1%	-$6.33K	﹤0.01%	2149
2014 Q2	$435K	Sell	14,403 -1,987	-12%	-$54.8K	﹤0.01%	2114
2014 Q1	$454K	Buy	16,390 +500	+3%	+$13.1K	﹤0.01%	2114
2013 Q4	$406K	Buy	15,890 +1,046	+7%	+$32.2K	﹤0.01%	2186
2013 Q3	$444K	Buy	14,844 +207	+1%	+$5.76K	﹤0.01%	2008
2013 Q2	$421K	Buy	+14,637	New	+$403K	﹤0.01%	1953

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

BlackRock Advisors's BRLI Position: Q3 2015 in Review

BlackRock Advisors sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 16,390 shares — an estimated $676K sold.

BlackRock Advisors first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $676K in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

BlackRock Advisors reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
BlackRock Advisors sold 16,390 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $676K.
BlackRock Advisors first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
BlackRock Advisors's BIO-REFERENCE LABS INC-NEW- position peaked at $676K in Q2 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on BlackRock Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.